- Crucell Announces Start of Phase II Clinical Study Rabies ... - FOXBusiness
- AP Pharma Reports Results for the Third Quarter 2008 - MarketWatch
- Sequenom Reports 2008 Second Quarter Financial Results - MarketWatch
- Biodel Announces Preliminary Results of Pivotal Phase III Clinical ... - MarketWatch
- Oculus Innovative Sciences Announces Fiscal Second Quarter ... - MarketWatch
Crucell Announces Third Quarter 2008 Results - MarketWatch
Crucell Announces Third Quarter 2008 ResultsMarketWatch - 6 hours agoCrucell presented positive preliminary results of the Phase II clinical study of its rabies monoclonal antibody combination in the United States. ...
